A 3’-UTR polymorphism in the oxidized LDL receptor 1 gene increases Aβ40 load as cerebral amyloid angiopathy in Alzheimer’s disease
It is presently unclear whether polymorphic variations in the oxidized low-density lipoprotein receptor 1 (OLR1), or low-density lipoprotein receptor-related protein 1 (LRP1), genes act as risk factors for Alzheimer’s disease (AD). In the present study, we have investigated the extent of amyloid β protein (Aβ) deposition as cerebral amyloid angiopathy (CAA) or senile plaques (SP) in relationship to OLR1 +1071 and +1073 polymorphisms and LRP1 C766T polymorphism in patients with AD There was an increased Aβ40 load as CAA, but not as SP, in frontal cortex of AD patients carrying OLR1+1073 CC genotype, compared to those with CT, TT or CT+TT genotypes, but only in those individuals without apolipoprotein (APOE) ε4 allele. No differences in total Aβ or Aβ42 load as CAA or SP between OLR1+1073 genotypes was seen, nor were there any differences between OLR1+1071 and LRP1 genotypes for any measure of Aβ. Present data suggests that homozygosity for the C allele for OLR1+1073 polymorphism, selectively in individuals without APOE ε4 allele, may impair clearance of Aβ, and particularly Aβ40, from the brain across the blood-brain barrier, leading to its ‘diversion’ into perivascular drainage channels, thereby increasing the severity of CAA in such persons.
KeywordsAlzheimer’s disease OLR1 gene LRP1 gene Cerebral amyloid angiopathy Amyloid β protein
- 16.Mann DMA, Iwatsubo T, Ihara Y, Cairns NJ, Lantos PL, Bogdanovic N, Lannfelt L, Winblad B, Maat-Schieman MLC, Rossor MN (1996) Predominant deposition of amyloid β42(43) in plaques in cases of Alzheimer’s disease and hereditary cerebral haemorrhage associated with mutations in the amyloid precursor protein gene. Am J Pathol 148:1257–1266PubMedGoogle Scholar
- 20.Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Belle G van, Berg L (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486PubMedGoogle Scholar
- 24.Pritchard A, Harris J, Pritchard CW, St Clair D, Lemmon H, Lambert JC, Chartier-Harlin MC, Hayes A, Thaker U, Iwatsubo T, et al (2005) Association study and meta-analysis of low density lipoprotein receptor related protein in Alzheimer’s disease. Neurosci Lett 382:221–226CrossRefPubMedGoogle Scholar
- 27.Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W, et al (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer’s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer’s disease. Nat Med 2:864–870CrossRefPubMedGoogle Scholar
- 29.Scott WK, Grubber JM, Conneally PM, Small GW, Hulette CM, Rosenberg CK, Saunders AM, Roses AD, Haines JL, Pericak-Vance MA (2000) Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: potential genetic and phenotypic heterogeneity. Am J Hum Genet 66:922–932CrossRefPubMedGoogle Scholar